Legal Representation
Attorney
Diane L. Gardner
USPTO Deadlines
Next Deadline
604 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-07-06)
Due Date
July 06, 2027
Grace Period Ends
January 06, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 4, 2024 | WOAG | I | WITHDRAWAL OF ATTORNEY GRANTED | Loading... |
| Dec 4, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 4, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Dec 4, 2024 | WOAR | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED | Loading... |
| Dec 4, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 4, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Dec 4, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 20, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Apr 20, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 20, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jul 6, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 20, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 20, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 31, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 12, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 8, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 25, 2020 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Nov 24, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 12, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Antibacterial pharmaceuticals; Antibacterial substances for medical purposes; Cells for medical or clinical use; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Intravenous bags sold filled with sipuleucel-T; Pharmaceutical preparations for the treatment and prevention of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations for cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of cancer; Pharmaceuticals, namely, anti-infectives; Therapeutic pharmaceutical for the treatment of cancer, infectious diseases, autoimmune diseases, allergies, and genetically induced conditions; Living cells for medical use; Pharmaceutical preparations for the treatment of infectious diseases
First Use Anywhere:
Apr 29, 2010
First Use in Commerce:
Apr 29, 2010
Additional Information
Design Mark
The mark consists of the term "Dendreon" having a capital "D" and lowercase "endreon" in combination with a design element, the design element consisting of two discrete parts located above the adjacent letters "e," "o," and "n," the first part being a feather shape having two pointed ends, the upper side of which is formed by a convex arc, and the lower side of which is formed by an elongated sine wave shape, resulting in the left side of the feather being thin and quill-shaped, and the right side of the feather being wider and rounder, the whole of the feather-shaped first part extending from the left side of the "e" slightly upward to the right side of the "o"; and the second part of the design element consisting of the x-axis mirror image of the first part, located to its right, such that the upper side of the feather-shaped second part is formed by an elongated cosine wave shape and the lower side is formed by a concave arc, with the whole of the feather-shaped second part extending from the left side of the "o" slightly upward to the right side of the "n," resulting in the right half of the feather-shaped first part overlapping with the left half of the feather-shaped second part; and a tag line portion below the term "Dendreon" consisting of the phrase "Targeting Cancer, Transforming Lives" in title case.
Classification
International Classes
005